|Bid||9.75 x 1300|
|Ask||9.76 x 2200|
|Day's range||9.20 - 9.90|
|52-week range||3.71 - 19.68|
|Beta (5Y monthly)||3.11|
|PE ratio (TTM)||44.72|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
What happened Shares of major marijuana stocks including Canopy Growth (NASDAQ: CGC), Aurora Cannabis (NYSE: ACB), HEXO (NYSE: HEXO), Charlotte's Web (OTC: CWBHF), and Aphria (NASDAQ: APHA) dropped amid the tech stock sell-off this morning.
The latest cannabis company to turn a profit was Tilray (NASDAQ: TLRY), achieving that mark earlier than both Aurora Cannabis (NYSE: ACB) and Canopy Growth (NASDAQ: CGC). Let's take a look at what changed for Tilray this quarter and whether it is a better buy than two of its key rivals. Tilray comes through on its promise -- but should investors be impressed?
Although estimates vary wildly, as we'd expect from an industry that's existed for decades in the black market, North American pot sales have the opportunity to reach $75 billion annually by the end of the decade. As we move headlong into March and look forward to warmer weather, investors would be wise to avoid the following three pot stocks like the plague.